Mild ischemic Injury Leads to Long-Term Alterations in the Kidney: Amelioration by Spironolactone Administration

Administration of the mineralocorticoid receptor antagonist spironolactone prevents the development of chronic kidney disease (CKD) after a severe ischemic injury. However, whether brief periods of ischemia lead to CKD and whether spironolactone administration after ischemia may be a useful therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrera-Chimal, Jonatan, Pérez-Villalva, Rosalba, Ortega, Juan Antonio, Sánchez, Andrea, Rodríguez-Romo, Roxana, Durand, Marta, Jaisser, Frederic, Bobadilla, Norma A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495407/
https://www.ncbi.nlm.nih.gov/pubmed/26157344
http://dx.doi.org/10.7150/ijbs.11729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495407/
https://www.ncbi.nlm.nih.gov/pubmed/26157344
http://dx.doi.org/10.7150/ijbs.11729

Ejemplares similares